![]() |
市場調查報告書
商品編碼
1289042
神經影像技術的進步和增長機會Neuroimaging Technology Advances and Growth Opportunities |
這份報告探討了神經影像行業,預測了未來五年 MRI 和 CT 在診斷影像和治療計劃方面的發展,以及這些新興技術在個性化醫療和精準神經病學方面的潛力。我們提供有關影響的信息
Innovation in MRI, CT Imaging Techniques and Integration of AI Making Neuroimaging More Patient-centric, and Personalized
The neuroimaging industry is dynamic, constantly looking for novel approaches to identify and cure complex neurological disorders. Emerging MRI and CT technologies have helped address the challenges in neuroimaging, such as limited spatiotemporal resolution, cost and accessibility, and patient safety.
This study examines emerging technologies, such as magnetic resonance fingerprinting (MRF), magnetic particle imaging (MPI), positron emission tomography-MR imaging (PET-MRI), silent ZTE (Zero Echo Time) MRI, photon-counting computerized tomography (PCCT), PET-CT, bedside CT, dual-energy CT, and AI-based MRI and CT technologies. Additionally, the study explores the potential benefits and outcomes of partnerships between top-tier neuroimaging companies and predictive AI startups, highlighting stakeholders in the competitive industry.
The study predicts the evolution of MRI and CT across diagnostic imaging and treatment planning in the next five years; and it explores the potential impact of these emerging technologies on personalized medicine and precision neurology. These advancements can potentially transform the diagnosis and treatment of neurological disorders. Finally, this Frost & Sullivan study suggests the growth opportunities in early-stage MRI and CT with the expanding applications of Neuroimaging-as-a-Service (NaaS) in neuromarketing and sleep deprivation management.